5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer

NCT01749956 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

RADIATION: Radiation
DRUG: Aflibercept
PROCEDURE: Surgery
DRUG: FOLFOX6

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]